Get the Stockscreener App
1.15
4.17%
-0.05
After Hours:
1.15
Park Ha Biological Technology Co Ltd stock is traded at $1.15, with a volume of 13,980.
It is down -4.17% in the last 24 hours and up +9.52% over the past month.
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
See More
Previous Close:
$1.20
Open:
$1.2
24h Volume:
13,980
Relative Volume:
0.06
Market Cap:
$3.70M
Revenue:
$2.52M
Net Income/Loss:
$-24.36M
P/E Ratio:
-0.0278
EPS:
-41.3755
Net Cash Flow:
$-2,900
1W Performance:
+6.48%
1M Performance:
+9.52%
6M Performance:
-92.73%
1Y Performance:
+0.00%
1-Day Range:
$1.15
$1.24
1-Week Range:
$1.04
$1.24
52-Week Range:
$0.9301
$19.75
Park Ha Biological Technology Co Ltd Stock (BYAH) Company Profile
Name
Park Ha Biological Technology Co Ltd
Sector
Industry
Phone
-
Address
-
Compare BYAH vs PG, UL, CL, KVUE, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BYAH
Park Ha Biological Technology Co Ltd
|
1.15 | 3.86M | 2.52M | -24.36M | -2,900 | -41.38 |
PG
Procter Gamble Co
|
144.90 | 333.97B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
58.42 | 128.22B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
86.33 | 68.31B | 20.80B | 2.22B | 3.77B | 2.5772 |
KVUE
Kenvue Inc
|
17.37 | 32.93B | 15.12B | 1.47B | 1.72B | 0.764 |
KMB
Kimberly Clark Corp
|
97.20 | 31.75B | 16.56B | 1.75B | 1.84B | 6.36 |
Park Ha Biological Technology Co Ltd Stock (BYAH) Latest News
Park Ha Biological Technology Co., Ltd. (PHH) Competitors - Meyka
Park Ha Biological Technology : Amendment to Annual Report by Foreign Issuer (Form 20-F/A) - marketscreener.com
19,050,000 Class B Ordinary Shares of Park Ha Biological Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-APR-2026. - marketscreener.com
[20-F/A] Park Ha Biological Technology Co., Ltd. Amends Annual Report (Foreign Issuer) - Stock Titan
Park Ha Bio (BYAH) Stock: Key Drivers Analysis (-2.29%) 2026-04-20Volume Spike - Xã Thanh Hà
Yanan Shan Net Worth (2026) - GuruFocus
Park Ha Bio (BYAH) Stock: Warning Signs (Technical Weakness) 2026-04-18Beta Signals - Xã Châu Thành
Qixiong Sheng Net Worth (2026) - GuruFocus
Xiaozhong Yu Net Worth (2026) - GuruFocus
Xiaoyan Zhu Net Worth (2026) - GuruFocus
Xiaoqiu Zhang Net Worth (2026) - GuruFocus
Xinyu Li Net Worth (2026) - GuruFocus
Park Ha Biological (BYAH) files $300M shelf to sell shares, warrants, debt - Stock Titan
Rosen Law Firm Encourages Park Ha Biological Technology Co. Ltd. Investors to Inquire About Securities Class Action Investigation – BYAH - Business Wire
Stock List: Research Stocks from Around the World - GuruFocus
Park Ha Biological Tech (BYAH) Stock Analysis Report | Financials & Insights - Benzinga
Market Recap: Can NCR Voyix Corporation disrupt its industryQuarterly Earnings Report & Smart Allocation Stock Reports - baoquankhu1.vn
Volatility Watch: Is Dynagas LNG Partners LP Preferred Security a speculative investment2026 Update & Stepwise Trade Signal Implementation - baoquankhu1.vn
Is Park Ha Bio (BYAH) Stock a Buy Now | Price at $1.03, Down 3.55%Growth Investing - Newser
Gains Report: Can YEXT withstand a market correction2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Is Park Ha Bio (BYAH) Stock exposed to global risks | Price at $1.05, Up 2.94%Retail Picks - Newser
AXIL PE Ratio & Valuation, Is AXIL Overvalued - Intellectia AI
Targets Report: What is the earnings history of Park Ha Biological Technology Co Ltd2026 Technicals & Expert-Curated Trade Recommendations - baoquankhu1.vn
Park Ha Biological (BYAH) CFO discloses 2,500 Class A shares - Stock Titan
Will Park Ha Bio (BYAH) Stock Miss Expectations | Price at $1.02, Down 2.86%Most Watched Stocks - Newser
BYAH PE Ratio & Valuation, Is BYAH Overvalued - Intellectia AI
BYAH Stock Analysis: Park Ha Biological Technology posts 0.96% gain at 1.05 in biotech - Newser
BYAH : Park Ha Biological Technology Co., Ltd. Key Company Metrics & Non-finance Metrics - Zacks Investment Research
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - Benzinga
Short Covering: Does Park Ha Biological Technology Co Ltd have declining or rising EPS2026 Technical Overview & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Aug Outlook: Is Park Ha Biological Technology Co Ltd stock heavily shorted2026 Analyst Calls & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Stock Recap: What is the earnings history of Park Ha Biological Technology Co Ltd2026 Catalysts & Comprehensive Market Scan Insights - baoquankhu1.vn
S P Trends: What are Park Ha Biological Technology Co Ltds earnings expectationsQuarterly Profit Report & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Chart Watch: Will Park Ha Biological Technology Co Ltd outperform its industry peersEarnings Growth Report & AI Forecasted Stock Moves - baoquankhu1.vn
BYAH Should I Buy - Intellectia AI
Momentum Shift: Is Park Ha Biological Technology Co Ltd exposed to political riskTrade Volume Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Short Covering: Can Park Ha Biological Technology Co Ltd be the next market leader2026 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
BYAH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Park Ha Biological Technology Announces Director Li Wang’s Resignation - tipranks.com
Director Li Wang resigns from Park Ha Biological (BYAH) board - Stock Titan
11 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session - Benzinga
Returns Recap: What is the earnings history of Park Ha Biological Technology Co LtdWeekly Stock Recap & Pattern Based Trade Signal System - baoquankhu1.vn
Movement Recap: What is the implied volatility of Park Ha Biological Technology Co. Ltd2026 Setups & Daily Momentum Trading Reports - baoquankhu1.vn
Will XXGCC stock outperform growth indexesMarket Sentiment Report & Growth Focused Stock Pick Reports - Naître et grandir
Park Ha Biological Technology regains Nasdaq minimum bid price compliance - Investing.com Australia
Gains Report: Is Park Ha Biological Technology Co Ltd still a buy after recent gainsWeekly Market Summary & Pattern Based Trade Signal System - baoquankhu1.vn
Park Ha Biological Technology regains Nasdaq minimum bid price compliance By Investing.com - Investing.com South Africa
Park Ha Biological Technology Regains Nasdaq Minimum Bid Price Compliance - TipRanks
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session - Benzinga
Sentiment Watch: What is the earnings history of Park Ha Biological Technology Co LtdJuly 2025 Market Mood & Consistent Growth Equity Picks - baoquankhu1.vn
China rules and HFCAA risks shape Park Ha Biological (NASDAQ: BYAH) outlook - Stock Titan
Park Ha Biological Technology Co Ltd Stock (BYAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
3.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):